The Patent Finder

Terms ending in 2035

Irm LLC

Every in-force patent on Irm LLC's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,422,007Markers Associated with WNT Inhibitors
In force
 · High confidence
Irm LLCIn forceHigh confidence
US 9,902,730Compounds and Compositions as Toll-Like Receptor 7 Agonists
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,944,649Compounds and Compositions as Toll-Like Receptor 7 Agonists
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,407,431Compounds and Compositions as Toll-Like Receptor 7 Agonists
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,844,068Compounds and Compositions as Toll-Like Receptor 7 Agonists
In force
 · High confidence
Novartis AGIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Irm LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited